Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CA$ 0.08
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Data is available to registered users only
Buy
Sell